- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 13.62M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 30.14M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 10.13M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $2K |
| Capex | Q1 2026 · Mar 31, 2025 | $47K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$17.3M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$21.78M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $186.63M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $15.48M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $151.23M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$6.67M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$5.29M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $18.43M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $38.36M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $30.62M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $38.51M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $30.73M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $188.76M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $22.87M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $189.74M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $24.05M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.08 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$2.51 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.08 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$2.51 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $7.61M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $5.29M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $25.63M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $21.53M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$32.59M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$25.47M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$33.24M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$26.83M |